Stifel sees ‘flurry of potential near-to-intermediate-term drivers’ for Glaukos

Stifel sees a “flurry of potential near-to-intermediate-term drivers” for Glaukos and believes the most important catalysts in the near-term include the outcome of the proposed MIGS LCDs, additional MACs finalizing the infinite professional fee, publication of iDose peer-reviewed literature and the late-December iDose PDUFA deadline. The firm’s sum-of-the-parts valuation analysis suggests upside in the stock exists in the $85-$90 range, with a floor of $55-$60 per share, but the firm adds that “potential near-to-intermediate-term drivers for Glaukos can vault the stock beyond the upside case.” Stifel has a Buy rating and $90 price target on Glaukos shares.